Your browser doesn't support javascript.
loading
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
Hsiang, Michelle S; Ntuku, Henry; Roberts, Kathryn W; Dufour, Mi-Suk Kang; Whittemore, Brooke; Tambo, Munyaradzi; McCreesh, Patrick; Medzihradsky, Oliver F; Prach, Lisa M; Siloka, Griffith; Siame, Noel; Gueye, Cara Smith; Schrubbe, Leah; Wu, Lindsey; Scott, Valerie; Tessema, Sofonias; Greenhouse, Bryan; Erlank, Erica; Koekemoer, Lizette L; Sturrock, Hugh J W; Mwilima, Agnes; Katokele, Stark; Uusiku, Petrina; Bennett, Adam; Smith, Jennifer L; Kleinschmidt, Immo; Mumbengegwi, Davis; Gosling, Roly.
Afiliação
  • Hsiang MS; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. E
  • Ntuku H; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Roberts KW; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Dufour MK; Division of Prevention Science, University of California San Francisco, San Francisco, CA, USA.
  • Whittemore B; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Tambo M; Multidisciplinary Research Centre, University of Namibia, Windhoek, Namibia.
  • McCreesh P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Medzihradsky OF; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Prach LM; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Siloka G; Zambezi Ministry of Health and Social Services, Katima, Namibia.
  • Siame N; Zambezi Ministry of Health and Social Services, Katima, Namibia.
  • Gueye CS; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Schrubbe L; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Wu L; Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Scott V; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Tessema S; Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Greenhouse B; Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Erlank E; Wits Research Institute for Malaria, South African Medical Research Council Collaborating Centre for Multi-Disciplinary Research on Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Koekemoer LL; Wits Research Institute for Malaria, South African Medical Research Council Collaborating Centre for Multi-Disciplinary Research on Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Sturrock HJW; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Mwilima A; Zambezi Ministry of Health and Social Services, Katima, Namibia.
  • Katokele S; National Vector-Borne Diseases Control Programme, Namibia Ministry of Health and Social Services, Windhoek, Namibia.
  • Uusiku P; National Vector-Borne Diseases Control Programme, Namibia Ministry of Health and Social Services, Windhoek, Namibia.
  • Bennett A; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Smith JL; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA.
  • Kleinschmidt I; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Wits Research Institute for Malaria, South African Medical Research Council Collaborating Centre for Multi-Disciplinary Research on Malaria, School of Pathology, Faculty of Health Sciences, U
  • Mumbengegwi D; Multidisciplinary Research Centre, University of Namibia, Windhoek, Namibia.
  • Gosling R; Malaria Elimination Initiative, Global Health Group, University of California San Francisco, San Francisco, CA, USA; Multidisciplinary Research Centre, University of Namibia, Windhoek, Namibia.
Lancet ; 395(10233): 1361-1373, 2020 04 25.
Article em En | MEDLINE | ID: mdl-32334702
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Controle de Mosquitos / Malária Falciparum / Administração Massiva de Medicamentos / Combinação Arteméter e Lumefantrina / Antimaláricos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Assunto principal: Controle de Mosquitos / Malária Falciparum / Administração Massiva de Medicamentos / Combinação Arteméter e Lumefantrina / Antimaláricos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article